A new trading day began on Tuesday, with PDS Biotechnology Corporation (NASDAQ: PDSB) stock price up 4.65% from the previous day of trading, before settling in for the closing price of $2.15. PDSB’s price has ranged from $1.53 to $6.68 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 14.51%. With a float of $36.00 million, this company’s outstanding shares have now reached $36.82 million.
Let’s look at the performance matrix of the company that is accounted for 25 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
PDS Biotechnology Corporation (PDSB) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of PDS Biotechnology Corporation is 3.76%, while institutional ownership is 11.58%.
PDS Biotechnology Corporation (PDSB) Latest Financial update
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.35 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.35 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 14.51% per share during the next fiscal year.
PDS Biotechnology Corporation (NASDAQ: PDSB) Trading Performance Indicators
Here are PDS Biotechnology Corporation’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.84.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.17, a number that is poised to hit -0.31 in the next quarter and is forecasted to reach -1.42 in one year’s time.
Technical Analysis of PDS Biotechnology Corporation (PDSB)
PDS Biotechnology Corporation (NASDAQ: PDSB) saw its 5-day average volume 0.35 million, a negative change from its year-to-date volume of 0.61 million. As of the previous 9 days, the stock’s Stochastic %D was 77.02%. Additionally, its Average True Range was 0.22.
During the past 100 days, PDS Biotechnology Corporation’s (PDSB) raw stochastic average was set at 24.91%, which indicates a significant decrease from 48.65% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 112.87% in the past 14 days, which was higher than the 75.30% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.00, while its 200-day Moving Average is $3.48. Nevertheless, the first resistance level for the watch stands at $2.32 in the near term. At $2.39, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.50. If the price goes on to break the first support level at $2.14, it is likely to go to the next support level at $2.04. The third support level lies at $1.97 if the price breaches the second support level.
PDS Biotechnology Corporation (NASDAQ: PDSB) Key Stats
With a market capitalization of 84.17 million, the company has a total of 37,409K Shares Outstanding. Currently, annual sales are 0 K while annual income is -42,940 K. The company’s previous quarter sales were 0 K while its latest quarter income was -10,730 K.
